Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127527881 | 12752788 | 1 | I | 200907 | 20160901 | 20160916 | 20160916 | EXP | US-CIPLA LTD.-2016US18272 | CIPLA | 0.00 | Y | 0.00000 | 20160916 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127527881 | 12752788 | 1 | PS | Tenofovir | TENOFOVIR | 1 | Unknown | UNK | U | 78800 | |||||||||
| 127527881 | 12752788 | 2 | SS | Tenofovir | TENOFOVIR | 1 | Unknown | UNK, ANOTHER SET | U | 78800 | |||||||||
| 127527881 | 12752788 | 3 | SS | Doxorubicin | DOXORUBICIN | 1 | Unknown | UNK, SIX CYCLES | U | U | 0 | ||||||||
| 127527881 | 12752788 | 4 | SS | DACARBAZINE. | DACARBAZINE | 1 | 100 MG/M2, THREE DAYS FOR EIGHT CYCLES | U | 0 | 100 | MG/M**2 | ||||||||
| 127527881 | 12752788 | 5 | SS | DACARBAZINE. | DACARBAZINE | 1 | Unknown | UNK, SIX CYCLES | U | 0 | |||||||||
| 127527881 | 12752788 | 6 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | 2.5 G/M2, FOR THREE DAYS EVERY THREE WEEKS | U | 0 | |||||||||
| 127527881 | 12752788 | 7 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 127527881 | 12752788 | 8 | SS | MESNA. | MESNA | 1 | Unknown | UNK, DAILY FOR THREE DAYS FOR EIGHT CYCLES | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127527881 | 12752788 | 1 | Retroperitoneal mass |
| 127527881 | 12752788 | 2 | Liposarcoma recurrent |
| 127527881 | 12752788 | 3 | Liposarcoma |
| 127527881 | 12752788 | 4 | Liposarcoma |
| 127527881 | 12752788 | 5 | Liposarcoma recurrent |
| 127527881 | 12752788 | 6 | Liposarcoma recurrent |
| 127527881 | 12752788 | 7 | Retroperitoneal mass |
| 127527881 | 12752788 | 8 | Liposarcoma recurrent |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127527881 | 12752788 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127527881 | 12752788 | Disease progression | |
| 127527881 | 12752788 | Disease recurrence | |
| 127527881 | 12752788 | Hepatitis B | |
| 127527881 | 12752788 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127527881 | 12752788 | 4 | 201012 | 0 | ||
| 127527881 | 12752788 | 6 | 201012 | 0 | ||
| 127527881 | 12752788 | 8 | 201112 | 0 |